Home / Guides / Semaglutide microdosing
Thinking about a lower dose? Read this first.
Semaglutide microdosing: what a low dose can and can’t do
By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated
Semaglutide microdosing means taking less than Wegovy’s label uses, such as a fraction of its 0.25 mg starting dose, or staying on a starting step. No trial has tested it as a way to manage weight, and the label has no microdose (read November 1, 2026); your provider decides your dose. At NexLife, compounded semaglutide is $95 a month on the 12-month plan, or $109 month to month, at every dose, microdose included.
$95/mo on 12 months, every dosePrice Match Guarantee†
- No microdose on Wegovy’s label: 0.25 mg is its lowest dose, for starting only
- Low daily doses led to some weight loss in a 2018 trial, less than higher doses
- Your provider decides your dose, and your price stays the same
$95/mo on a 12-month plan, all-inclusive, same price at every dose
Or $109/mo month to month
Microdose or full dose: your price stays the same at every dose
About 3 minutes of health questions · No insurance needed · Not prescribed? No charge for medication
See all 4 plans and what a year costs
| Plan | Per month | 12 months at this rate |
|---|---|---|
| 12-month Lowest monthly price | $95 | $1,140 |
| 6-month | $99 | $1,188 |
| 3-month | $105 | $1,260 |
| Month to month | $109 | $1,308 |
Month to month costs $168 more over 12 months than the 12-month plan. Plans renew until you cancel. Longer plans bill the way you choose at checkout.
Price Match Guarantee†. Paying less elsewhere? We match your regular monthly price. How it works
4.8 out of 5 on Trustpilot, 407 reviewsLegitScript-certified
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. The vial shown is an illustration. Always use the strength on your pharmacy’s label.
- Licensed U.S. providers
- LegitScript certified
- Free expedited shipping
- HSA, FSA, Affirm, Klarna, Afterpay
- 24/7 support, real people
- Filled by Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA)
At a glance
Semaglutide microdosing at a glance
The short answers, from Wegovy’s label and the trials. Each one is explained below.
| Question | Answer |
|---|---|
| What is microdosing? | Taking less semaglutide than Wegovy’s label uses: a fraction of a starting dose, staying on a starting step, or splitting a weekly dose. There’s no official definition. |
| Is it FDA-approved? | No. Wegovy’s label has no microdose: 0.25 mg, 0.5 mg and 1 mg are starting steps, and maintenance is 1.7 mg or 2.4 mg. |
| Has it been tested? | Not as a weekly microdose plan. In a 2018 trial of daily doses, the lowest, 0.05 mg a day, led to 6.0% average weight loss in a year, against 2.3% on placebo and 13.8% on 0.4 mg a day. |
| Fewer side effects? | Possibly fewer stomach side effects, which were more common at higher doses in that trial, but no trial measured them on a microdose. The label’s warnings apply at every dose. |
| What’s the lowest labeled dose? | 0.25 mg once a week, for the first 4 weeks. Ozempic’s first label said that dose “is not effective for glycemic control.” |
| What does NexLife charge? | $95 a month on the 12-month plan, or $109 month to month, at every dose, microdose included. |
The trials studied semaglutide made by Novo Nordisk; compounded semaglutide wasn’t studied, and it isn’t FDA-approved. NexLife’s prices as of November 5, 2026.
- Tell us about you About 3 minutes of health questions
- A licensed provider decides You’re prescribed only if it’s right for you
- Your partner pharmacy ships Usually within 1 to 2 business days, free
Key takeaways
- No microdose is on Wegovy’s label. Its 0.25 mg, 0.5 mg and 1 mg doses are starting steps; maintenance is 1.7 mg or 2.4 mg.
- Low doses did something in one trial. In a 2018 trial of daily semaglutide, 0.05 mg a day led to 6.0% average weight loss over 52 weeks, against 2.3% on placebo. Higher doses did more.
- Dose mattered in STEP 2: in adults with type 2 diabetes, average weight loss over 68 weeks was 7.0% on 1 mg a week and 9.6% on 2.4 mg, against 3.4% on placebo.
- Wellness and longevity claims aren’t backed by trials. Researchers quoted by STAT say there’s no robust clinical evidence that very small doses work.
- Small doses mean tiny volumes. At an example strength of 5 mg per mL, 0.1 mg is 2 units, so 1 unit off is half the dose.
- At NexLife, every dose costs the same: $95 a month on the 12-month plan, or $109 month to month.
The basics
What is semaglutide microdosing?
There’s no official definition. People use the word for a few different plans, and none of them is on Wegovy’s label (revised June 2026). A lower maintenance dose, 1.7 mg, is on the label.
| What people mean | What it looks like | On Wegovy’s label? |
|---|---|---|
| A dose below 0.25 mgthe usual meaning | A fraction of the starting dose, measured from a compounded vial. | No: 0.25 mg is the lowest dose |
| Staying on a starting step | Holding 0.25 mg, 0.5 mg or 1 mg for months instead of moving up. | No: those doses are starting steps |
| Splitting the weekly dose | Half the dose, twice a week, as Remedy Meds offers. | No: every dose is once a week |
| A lower maintenance dosenot microdosing | 1.7 mg instead of 2.4 mg, from week 17. | Yes: both are maintenance doses |
Swipe the table sideways to see every column.
Four ways people lower their semaglutide dose, against the Wegovy prescribing information (revised June 2026), read November 1, 2026. Example plans are from programs’ own pages, checked November 1, 2026.
“The 0.25 mg dose is intended for treatment initiation and is not effective for glycemic control.”
Novo Nordisk, Ozempic (semaglutide) injection prescribing information, December 2017, via Drugs@FDA
Why a microdose usually means compounded semaglutide. Wegovy pens each give one set dose, from 0.25 mg to 2.4 mg, or 7.2 mg for Wegovy HD. A smaller dose has to be measured with a syringe from a compounded vial, and compounded semaglutide isn’t FDA-approved.
Ozempic and the Wegovy pill don’t change that. Ozempic pens hold several doses but give set amounts, and Ozempic is for type 2 diabetes. The Wegovy pill starts at 1.5 mg a day, a starting step on the way to 25 mg.
Why people ask
Why do people consider microdosing semaglutide?
Five reasons come up most. For each one, there’s a better-studied option to ask your provider about first.
| Why people ask | What the evidence says | Ask your provider about |
|---|---|---|
| Side effects on the way up | Nausea affected 44% of people on Wegovy 2.4 mg in its trials, versus 16% on placebo. The label raises the dose every 4 weeks, through week 16, to lower that risk. | How you’re tolerating each step before the next one |
| Keeping weight off after a goal | No trial in Wegovy’s label tested stepping down after a goal. In STEP 4, weight rose 6.9% over 48 weeks after people switched to placebo. | Whether 1.7 mg, the label’s lower maintenance dose, fits you |
| Cost | A smaller dose uses less medicine, but many programs charge one price at every dose, and the microdose plans we track cost $149 to $179 a month after any first-month offer. | The price at your dose, in writing |
| A lower BMI | Wegovy’s trials enrolled adults with a BMI of 30 or more, or 27 or more with a weight-related condition. Below that, any dose is off-label. | Whether the benefits outweigh the risks for you |
| Wellness, longevity or inflammation | Not shown in trials. Researchers quoted by STAT say there’s no robust clinical evidence for very small doses, and a 2026 review found the direct evidence “extremely limited,” News-Medical reports. | What you hope to gain, and how you’d measure it |
Swipe the table sideways to see every column.
Why people consider a semaglutide microdose, what the evidence on this page says, and what to ask instead. From the Wegovy prescribing information (revised June 2026), STEP 4 (JAMA, 2021) and programs’ own pages, checked November 1, 2026.
The evidence
What do trials show about low doses of semaglutide?
More semaglutide meant more weight loss, on average, in the trials we found. The best low-dose data comes from a 2018 trial of daily doses. No trial has tested weekly microdosing as a plan.
957 adults with obesity and without diabetes, given daily shots for 52 weeks, with diet and activity counseling (O’Neil et al., The Lancet, 2018, as reported by HCPLive). Weekly totals are our math. Daily shots aren’t a weekly microdose, and the trial studied semaglutide made by Novo Nordisk; compounded semaglutide wasn’t studied.
| Trial | Who and how long | Lowest dose tested | Highest dose tested | Placebo |
|---|---|---|---|---|
| 2018 dose-finding trialO’Neil et al., The Lancet | 957 adults with obesity, without diabetes; daily shots, 52 weeks | 0.05 mg a day: −6.0% | 0.4 mg a day: −13.8% | −2.3% |
| STEP 2Davies et al., The Lancet, 2021 | 1,210 adults with type 2 diabetes and overweight or obesity, 68 weeks | 1 mg a week: −7.0% | 2.4 mg a week: −9.6% | −3.4% |
| STEP 1Wilding et al., NEJM, 2021 | 1,961 adults with obesity or overweight, without diabetes, 68 weeks | 2.4 mg a week: −14.9% | The only dose tested | −2.4% |
Swipe the table sideways to see every column.
Three randomized trials of semaglutide, from the lowest dose each tested to the highest: a 52-week dose-finding trial of daily shots (O’Neil et al., The Lancet, 2018), STEP 2 in adults with type 2 diabetes (Davies et al., The Lancet, 2021) and STEP 1 in adults without diabetes (Wilding et al., NEJM, 2021). Average weight change, counting everyone randomized. They studied semaglutide made by Novo Nordisk; compounded semaglutide wasn’t studied.
A low dose isn’t no dose. In 2018, 0.05 mg a day, 0.35 mg a week in total, led to more weight loss than placebo over a year. But it was a daily shot, and higher doses did more.
No microdosing trial. We found no randomized trial of weekly semaglutide microdosing for weight, maintenance or wellness, as of November 5, 2026.
What a 2026 review found. A narrative review in Cureus (2026) gathered indirect evidence, such as pooled data suggesting better tolerability on 0.5 mg and 1 mg over time, and said prospective studies are needed. Its authors say the benefits of standard doses can’t be assumed to persist at fractional doses, News-Medical reports.
Side effects
Does microdosing semaglutide cause fewer side effects?
Possibly fewer stomach side effects, since they were more common at higher doses. But no trial has measured side effects on a microdose, and the label’s warnings apply at every dose.
| Side effect or risk | What the trials and label show | At a lower dose |
|---|---|---|
| Nausea, vomiting, diarrhea | Nausea affected 44% of people on Wegovy 2.4 mg in its trials, versus 16% on placebo, mostly while the dose was going up. | Likely less common: stomach side effects were more prominent at higher doses in the 2018 trial |
| Thyroid C-cell tumorsboxed warning | Caused tumors in rodents; it isn’t known whether it does in people. Don’t use it with a personal or family history of MTC, or with MEN 2. | The warning isn’t tied to dose |
| Pancreatitis, gallbladder problems | Serious side effects listed on the label. | Still possible: the warnings apply at every dose |
| Low blood sugar | Likelier with insulin or a sulfonylurea, the label says. | Still possible with those medicines |
| Vision changes with type 2 diabetes | A warning on the label for people with diabetic eye disease. | Tell your provider about any eye problems |
| Dosing errors | In a 2024 alert, the FDA reported people taking 5 to 20 times their intended dose of compounded semaglutide. | Higher risk: tiny volumes leave less room for error |
Swipe the table sideways to see every column.
From the Wegovy prescribing information (revised June 2026), the 2018 dose-finding trial and the FDA. No trial measured side effects on a microdose. The trials studied semaglutide made by Novo Nordisk; compounded semaglutide wasn’t studied.
Get help fast. Severe stomach pain that won’t go away: call your provider right away. Swelling of your face or throat, or trouble breathing: get emergency care.
Planning a pregnancy? Semaglutide should be stopped at least 2 months before a planned pregnancy; its half-life is about a week. Tell your provider right away if you’re pregnant.
Dose and vial math
How many units is a semaglutide microdose?
It depends on your vial’s strength, and tiny doses leave little room for error. At an example strength of 2.5 mg per mL, 0.25 mg is 0.1 mL, or 10 units on a U-100 syringe.
| Weekly dose | At 2.5 mg/mL (example) | At 5 mg/mL (example) |
|---|---|---|
| 0.1 mg | 0.04 mL (4 units) | 0.02 mL (2 units) |
| 0.125 mghalf the starting dose | 0.05 mL (5 units) | 0.025 mL (2.5 units) |
| 0.25 mgthe label’s starting dose | 0.1 mL (10 units) | 0.05 mL (5 units) |
| 0.5 mga starting step | 0.2 mL (20 units) | 0.1 mL (10 units) |
| 1 mga starting step | 0.4 mL (40 units) | 0.2 mL (20 units) |
The math: mL = dose ÷ strength (mg per mL); units = mL × 100. At 5 mg/mL, each unit holds 0.05 mg: 0.1 mg is 2 units, so 1 unit off is a 50% error.
These strengths are examples only. Strengths of compounded semaglutide vary by pharmacy, and one pharmacy may offer several. Your vial’s label decides the strength, and your prescription sets your dose.
“In these instances, patients administered five to 20 times more than the intended dose of semaglutide.”
U.S. Food and Drug Administration, FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, July 26, 2024
Check before you draw. The FDA says mix-ups between milliliters, milligrams and units may have contributed to those errors. If a number doesn’t match your prescription, ask your provider before you inject; at NexLife, call or text
A small dose can outlast its vial. USP Chapter 797, the sterile-compounding standard, calls for throwing out a multiple-dose vial 28 days after its first use, even if medicine is left, or by its beyond-use date if that comes first. On a microdose, there may be medicine left on day 28: throw it out anyway. More: compounded semaglutide storage.
After your goal
Can microdosing semaglutide keep weight off?
It hasn’t been tested. Wegovy’s label sets maintenance at 1.7 mg or 2.4 mg a week, and no trial in the label tested stepping down after a goal.
| Plan after your goal | Wegovy’s label | The evidence |
|---|---|---|
| Stay at 2.4 mg | A maintenance dose | STEP 4: people who stayed on it kept losing weight, on average |
| 1.7 mg | A maintenance dose | Not tested as a step-down after a goal |
| 1 mg or lower | A starting step | Not tested for maintenance |
| A microdose | Not in the label | Not studied |
| Stop | No stopping schedule | STEP 4: weight rose 6.9% over 48 weeks on placebo |
Swipe the table sideways to see every column.
From the Wegovy prescribing information (revised June 2026) and STEP 4 (Rubino et al., JAMA, 2021). These trials studied FDA-approved Wegovy; compounded semaglutide wasn’t studied.
Thinking of going lower? Agree with your provider how you’ll track your weight, and when you’ll check back in. The whole picture: semaglutide maintenance dose.
Tirzepatide has a step-down trial. In SURMOUNT-MAINTAIN, stepping down to 5 mg of tirzepatide held most of the loss, on average. Our tirzepatide microdosing guide covers it.
Claims vs. evidence
Semaglutide microdosing claims: what does the evidence support?
Microdosing is often marketed for more than weight. Here’s what the trials, reviews and statements on this page support, and what they don’t.
| The claim | What we found |
|---|---|
| It causes fewer side effects | Plausible: stomach side effects were more prominent at higher doses in the 2018 trial. But no trial measured them on a weekly microdose. |
| It works like a full dose | Not on the evidence we found. In 2018, 0.05 mg a day led to 6.0% average weight loss, and 0.4 mg a day to 13.8%. |
| It keeps weight off | Not tested. Wegovy’s label sets maintenance at 1.7 mg or 2.4 mg. |
| It lowers inflammation or slows aging | Not shown in trials. A 2026 review found the direct evidence extremely limited, News-Medical reports. |
| It’s FDA-approved | No. No FDA label includes a microdose, and compounded semaglutide isn’t FDA-approved. |
| It costs less | Not always. The microdose plans we track cost $149 to $179 a month after any first-month offer (checked November 1, 2026). At NexLife, it’s $95 a month on the 12-month plan, or $109 month to month, at every dose. |
Swipe the table sideways to see every column.
From the trials, the 2026 review, expert comments and programs’ pages cited on this page, read November 1 to 5, 2026.
“Whether these low doses actually combat inflammation is uncertain.”
Daniel Drucker, University of Toronto, quoted by ConsumerAffairs, GLP-1 microdoses not a good idea, doctors warn, January 16, 2026
Brand-name options
Can you microdose Wegovy or Ozempic?
Not as labeled. Wegovy pens each give one set dose, Ozempic pens give set amounts, and the Wegovy pill steps up from 1.5 mg a day.
| Brand-name option | How the dose works | Self-pay price |
|---|---|---|
| Wegovy pen | One set dose per pen, from 0.25 mg to 2.4 mg, or 7.2 mg for Wegovy HD | $199 for each of a new patient’s first two fills (through Dec. 31, 2026), then $349 a month ($399 at 7.2 mg) |
| Wegovy pill | One tablet a day: 1.5 mg, then 4 mg and 9 mg, then 25 mg from day 91 | $149 at 1.5 mg, $199 at 4 mg, $299 at 9 mg and 25 mg |
| Ozempic penfor type 2 diabetes | Several doses per pen, each a set amount | See Ozempic cost without insurance |
Swipe the table sideways to see every column.
From the Wegovy and Ozempic prescribing information and Novo Nordisk’s self-pay prices, checked November 1, 2026. Prices are for the medication alone. Ozempic is FDA-approved for type 2 diabetes, not for weight loss.
Pens are made for set doses. The labels have no partial doses, so splitting a pen dose isn’t a labeled use.
On Medicare? Since July 1, 2026, Medicare’s GLP-1 Bridge lets eligible Part D enrollees get the Wegovy pen or pill for weight loss at a $50 monthly copay, with prior authorization, through December 31, 2027.
Compare them. GLP-1 pills vs. injections, and compounded vs. brand-name semaglutide.
The rules
Is compounded semaglutide microdosing legal?
It can be: a licensed provider prescribes it for you, a state-licensed 503A pharmacy prepares it, and your prescriber documents a significant difference for you. It isn’t FDA-approved, and no microdose regimen is.
“…unless a prescriber determines and documents the compounded drug product contains a change that produces a significant difference from the commercially available drug product for an identified individual patient.”
U.S. Food and Drug Administration, FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (April 1, 2026)
A dose strength you can’t buy. Pharmacy Times lists the need for a dose strength that isn’t commercially available among the narrow exceptions for 503A pharmacies (May 1, 2026). Whether it applies to you is your prescriber’s call, and it has to be documented.
The shortage is over. The FDA determined the semaglutide shortage was resolved on February 21, 2025, so routine copies ended. The FDA proposed on April 30, 2026 to exclude semaglutide from the 503B bulks list; when we checked on November 5, 2026, we found no final decision.
Every rule, in the FDA’s words. The same rules cover both medicines: see is compounded tirzepatide legal? and semaglutide compounding pharmacies.
Cost
What does semaglutide microdosing cost?
The microdose plans we track cost $149 to $179 a month after any first-month offer (checked November 1, 2026). At NexLife, a microdose costs what every dose does: $95 a month on the 12-month plan, or $109 month to month.
| Program | What it is | To start | Then, a month | First 12 months |
|---|---|---|---|---|
| NexLife, 12-month plancompounded | Any dose your provider prescribes, microdose included | $95 | $95 | $1,140 |
| NexLife, month to monthcompounded | Any dose your provider prescribes, microdose included | $109 | $109 | $1,308 |
| Raeliva microdosecompounded | A low-dose plan, offered “for metabolic support as part of a longevity plan rather than for weight loss” | $149 | $149 | $1,788 |
| Noom microdose plancompounded | Low-dose semaglutide; billed $537 every 12 weeks | $79 the first 4 weeks | $179 | $2,048 |
| Henry Meds microdosecompounded | A semaglutide microdose plan; its page says it costs less each month but shows no price | Not shown | Not shown | Not shown |
| Wegovy pen, 0.25 mgbrand-name; a starting dose, not a microdose | The medication alone | $199 for each of a new patient’s first two fills (through Dec. 31, 2026) | $349 | Not a dose to stay on |
Swipe the table sideways to see every column.
Prices as each company lists them: Noom, Raeliva, Henry Meds and Novo Nordisk checked November 1, 2026; NexLife’s as of November 5, 2026. First 12 months is our math: at Noom, the first 4-week price, then 11 more 4-week supplies; at Raeliva and NexLife, 12 months at the monthly price. Noom’s prices are before tax. NexLife’s prices include the provider and shipping; Novo Nordisk’s is for the medication alone. Compounded medicines aren’t FDA-approved; Wegovy is.
Our math from each company’s listed prices: Noom and Raeliva checked November 1, 2026; NexLife’s as of November 5, 2026. Noom’s months are 4-week supplies. NexLife’s price is the same at every dose. The medicines are compounded, not FDA-approved.
Month one at Noom costs less. Its $79 start is $16 below NexLife’s 12-month plan. From month two, its $179 is $84 a month more than NexLife’s 12-month plan, and $70 more than NexLife month to month.
NexLife Price Match Guarantee†. Already on compounded semaglutide with another licensed provider, and paying less? We match your regular monthly price. How it works
Ask for the price at your dose, in writing. Some programs price by dose, and some charge one price at every dose. A dose tier or a dose step can change what you pay. Our Price Match Guarantee† matches regular month-to-month prices, not first-month offers or prepaid multi-month programs.
Compare more. Every dose, priced: semaglutide cost by dose. One price at every dose: flat-rate semaglutide. Our reviews: Noom, Raeliva, Henry Meds and Remedy Meds.
Is it for you?
Who shouldn’t microdose semaglutide?
Anyone who shouldn’t take semaglutide at any dose. A lower dose doesn’t change who the label says shouldn’t use it, or what to tell your provider first.
| If you | What the label says |
|---|---|
| Have had medullary thyroid carcinoma (MTC), or a family member has, or you have MEN 2 | Don’t use semaglutide, at any dose. |
| Have had a serious allergic reaction to semaglutide | Don’t use it. |
| Are pregnant, or planning to be | Tell your provider. Semaglutide should be stopped at least 2 months before a planned pregnancy. |
| Take insulin or a sulfonylurea | Low blood sugar is likelier; your provider may adjust those medicines. |
| Take another GLP-1 medicine | Don’t combine them. |
| Have had pancreatitis, gallbladder or kidney problems, severe stomach problems, or eye problems from diabetes | Tell your provider before you start. |
Swipe the table sideways to see every column.
From the Wegovy prescribing information (revised June 2026). Not a complete list: your provider reviews your full health history.
With your provider
How do you talk to your provider about a lower dose?
Start with what you want the lower dose to do. Then you can weigh a microdose against the labeled options together.
Say what you want from it
Fewer side effects, a lower cost, keeping weight off or something else: each one leads to a different plan.
Ask about the labeled options first
How you’re tolerating each starting step before the next one, or 1.7 mg instead of 2.4 mg for maintenance.
Agree on what you’ll watch
If you try a microdose, settle how you’ll track your weight and side effects, and when you’ll check back in.
Get the math in writing
Your dose in mg, your vial’s strength in mg per mL, the units to draw, and the date to throw the vial out.
Make every change together
Any change to your dose or your schedule goes through your provider.
At NexLife
Microdosing with NexLife
A licensed provider decides whether a microdose fits you, and your price doesn’t change with your dose. Here’s how it works.
A provider decides your dose
A licensed provider reviews your health history and decides whether to prescribe, and at what dose, including whether a microdose is right for you.
One price at every dose
$95 a month on the 12-month plan, or $109 month to month. A microdose costs what 2.4 mg does.
Clear dose instructions
Your label shows the strength in mg per mL, and your provider tells you your dose. Real people answer 24/7 at
(949) 818-8000 .Each refill ships free
Expedited shipping; most orders ship within 1 to 2 business days.
See the program. Plans and how to start: the microdose semaglutide program. A nutrition plan and a 1:1 coaching call are included.
Paying with HSA or FSA? Both work, and NexLife provides a letter of medical necessity. Affirm, Klarna and Afterpay are at checkout too.
What does NexLife cost?
One flat price at every dose.
No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†
GIP + 12-month plan $115/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $129/mo month to month.
Check my eligibilityCompounded, not FDA-approved · Not prescribed? No charge for medication
12-month plan $95/mo
Semaglutide
Weekly
Compounded, not FDA-approved · Not prescribed? No charge for medication
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms
The NexLife Price Match Guarantee†
Paying less elsewhere?
Keep your price. Upgrade your care.
Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.
Semaglutide microdosing: your questions
Fair questions about NexLife
- Will a microdose cost less?
- No. You pay the same at every dose, microdose included.
- What if I’m not prescribed?
- You aren’t charged for medication.
- Can I cancel?
- Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
- Do I need insurance?
- No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.
What is semaglutide microdosing?
Taking less semaglutide than Wegovy’s label uses, such as a fraction of the 0.25 mg starting dose, staying on a starting step, or splitting a weekly dose in two. There’s no official definition, and no FDA label includes a microdose. Your provider decides your dose.
What is a microdose of semaglutide in mg?
There’s no set amount. It usually means less than the label’s doses, such as part of the 0.25 mg starting dose, or holding 0.25 mg or 0.5 mg instead of moving up. Wegovy’s lowest dose, 0.25 mg, is only for starting. Your prescription sets your dose.
Does microdosing semaglutide work for weight loss?
It hasn’t been tested as a weekly plan. In a 2018 trial of daily shots, 0.05 mg a day led to 6.0% average weight loss in a year, against 2.3% on placebo and 13.8% on 0.4 mg a day. In STEP 2, 1 mg a week led to 7.0%, and 2.4 mg to 9.6%. These trials studied semaglutide made by Novo Nordisk, not compounded semaglutide.
Is semaglutide microdosing FDA-approved?
No. Wegovy’s label has no microdose: 0.25 mg, 0.5 mg and 1 mg are starting steps, and maintenance is 1.7 mg or 2.4 mg. Compounded semaglutide isn’t FDA-approved either; a provider prescribes it only when it offers a significant difference for you.
Does microdosing semaglutide reduce side effects?
It may reduce stomach side effects, which were more prominent at higher doses in a 2018 trial, but no trial has measured side effects on a microdose. Nausea affected 44% of people on Wegovy 2.4 mg in its trials, versus 16% on placebo. The label’s warnings, including the boxed warning on thyroid tumors, apply at every dose.
How many units is a microdose of semaglutide?
It depends on your vial’s strength. At an example strength of 2.5 mg per mL, 0.25 mg is 0.1 mL, or 10 units on a U-100 syringe; at 5 mg per mL, it’s 5 units, and 0.1 mg is 2 units. Use the strength on your own vial’s label, and ask your provider if the numbers don’t match.
Can I microdose semaglutide to keep weight off?
It hasn’t been tested. Wegovy’s label sets maintenance at 1.7 mg or 2.4 mg, and no trial in it tested stepping down after a goal. In STEP 4, weight rose 6.9% over 48 weeks after people switched to placebo. Your provider can help you weigh your options.
Can I split my semaglutide dose into two shots a week?
Not by the label: Wegovy is taken once a week, and no trial on this page tested twice-weekly shots. Some programs offer it, such as Remedy Meds’ half the dose, twice a week. If you’re on a split schedule, tell any new provider.
Can I microdose with an Ozempic or Wegovy pen?
Not as labeled. Wegovy pens each give one set dose, and Ozempic pens give set amounts; the labels have no partial doses. A dose below 0.25 mg needs a compounded vial and a syringe.
How long does a vial last on a microdose?
No more than 28 days after its first use, or until its beyond-use date if that comes first, even if medicine is left. That’s the USP Chapter 797 standard for multiple-dose vials. On a small dose, ask how much medicine each vial holds.
Can I microdose semaglutide with a lower BMI?
Wegovy’s trials enrolled adults with a BMI of 30 or more, or 27 or more with a weight-related condition; below that, any dose is off-label. NexLife’s microdose program pages say microdose options may be available from a BMI of 23. A licensed provider decides only after reviewing your health history.
Does microdosing semaglutide help with inflammation or aging?
That hasn’t been shown. A 2026 review found the direct evidence for GLP-1 microdosing extremely limited, News-Medical reports, and researchers quoted by STAT say there’s no robust clinical evidence that very small doses work.
How much does microdosing semaglutide cost at NexLife?
$95 a month on the 12-month plan, or $109 month to month: the same price at every dose, microdose included. That’s $1,140 or $1,308 a year, with no membership fee.
Is microdosing cheaper than a full dose?
Not always. At NexLife and many other programs, every dose costs the same. The microdose plans we track cost $149 to $179 a month after any first-month offer (checked November 1, 2026). Ask for the price at your dose in writing before you prepay.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at
† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.
Who wrote and medically reviewed this page?
Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.
Labels and trials read November 1 to 5, 2026. Other programs’ prices checked November 1, 2026.
- How we checked. The doses, schedule and warnings come from the Wegovy prescribing information (revised June 2026), and Ozempic’s first label (December 2017) via Drugs@FDA. The 2018 trial’s results come from HCPLive’s report of it; STEP 2’s from MIMS’s report of its paper in The Lancet; STEP 1’s and STEP 4’s as our other guides cite them. Expert comments are as quoted by ConsumerAffairs (January 16, 2026) and STAT (November 4, 2025), and the 2026 review as summarized by News-Medical (September 1, 2026). NexLife’s prices come from our pricing page (November 5, 2026); other programs’ prices are as our reviews list them, checked November 1, 2026. We don’t give a microdose: your provider decides.
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
Paying less elsewhere? We match it.†
Microdose or full dose? Your price stays the same.
Start online in about 3 minutes, and a licensed provider decides your dose. $95 a month on the 12-month plan, or $109 month to month, at every dose.
4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.
- 1Tell us about you
Start online with your health history.
- 2A licensed provider decides
Online, following your state’s rules. You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.
Sources
- Wegovy (semaglutide) injection and tablets, prescribing information, Novo Nordisk (revised June 2026). Read November 1, 2026.
- Novo Nordisk, via Drugs@FDA. Ozempic (semaglutide) injection prescribing information, December 2017. Read November 5, 2026.
- O’Neil PM et al. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. The Lancet 2018; 392: 637–49. Results as reported by HCPLive; read November 5, 2026.
- HCPLive. Semaglutide: more weight loss than placebo, no diabetes required (results by dose). Read November 5, 2026.
- Davies M et al. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). The Lancet 2021; 397: 971–84. Results as reported by MIMS and Consultant360; read November 5, 2026.
- MIMS. High-dose semaglutide improves glucose metabolism outcomes in overweight/obese patients with T2D (STEP 2). Read November 5, 2026.
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). The New England Journal of Medicine 2021. Read November 1, 2026.
- Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA 2021; 325: 1414–25. Record read November 1, 2026.
- ConsumerAffairs. GLP-1 microdoses not a good idea, doctors warn (January 16, 2026). Read November 5, 2026.
- News-Medical. GLP-1 drugs have benefits beyond weight loss. Could microdoses preserve them? (September 1, 2026), on Panlilio MA et al., Multisystem benefits of GLP-1 microdosing: a narrative review, Cureus 2026; 18(7): e113635. Read November 5, 2026.
- STAT. Microdosing aims to extend the lifespan of the GLP-1 compounding market (November 4, 2025). Read November 5, 2026.
- Noom Med: pricing (microdose semaglutide plan). Checked November 1, 2026.
- Raeliva: compounded microdose semaglutide. Checked November 1, 2026.
- Henry Meds: semaglutide microdose. Checked November 1, 2026.
- Remedy Meds: homepage, plans and microdose option. Checked November 1, 2026.
- Novo Nordisk: What to pay for Wegovy (self-pay prices). Checked November 1, 2026.
- U.S. Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (April 1, 2026). Read November 2, 2026.
- Pharmacy Times. FDA moves to permanently close the door on compounded GLP-1s (May 1, 2026). Read November 5, 2026.
- U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products (July 26, 2024). Read November 2, 2026.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. Read November 2, 2026.
- U.S. Pharmacopeia. USP General Chapter 797: Pharmaceutical Compounding, Sterile Preparations. Read November 2, 2026.
- Centers for Medicare & Medicaid Services. Medicare.gov: weight loss drugs (GLP-1 Bridge). Read November 1, 2026.
- NexLife: pricing, every plan. Checked November 5, 2026.
- NexLife: microdose semaglutide program. Checked November 5, 2026.
Get Started